🇺🇸 FDA
Patent

US 9982013

Readily isolated bispecific antibodies with native immunoglobulin format

granted A61KA61K2039/505

Quick answer

US patent 9982013 (Readily isolated bispecific antibodies with native immunoglobulin format) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505